Foracort Inhaler: Dual-Action Relief for Asthma and COPD Control
| Product dosage: 100mcg | |||
|---|---|---|---|
| Package (num) | Per inhaler | Price | Buy |
| 1 | $47.17 | $47.17 (0%) | 🛒 Add to cart |
| 2 | $38.14 | $94.35 $76.28 (19%) | 🛒 Add to cart |
| 3 | $33.46 | $141.52 $100.37 (29%) | 🛒 Add to cart |
| 4 | $31.62 | $188.70 $126.47 (33%) | 🛒 Add to cart |
| 5 | $30.11 | $235.87 $150.56 (36%) | 🛒 Add to cart |
| 6 | $28.77 | $283.05 $172.64 (39%) | 🛒 Add to cart |
| 7 | $27.53 | $330.22 $192.71 (42%) | 🛒 Add to cart |
| 8 | $26.47 | $377.39 $211.78 (44%) | 🛒 Add to cart |
| 9 | $25.54 | $424.57 $229.85 (46%) | 🛒 Add to cart |
| 10 | $25.39
Best per inhaler | $471.74 $253.94 (46%) | 🛒 Add to cart |
| Product dosage: 200mcg | |||
|---|---|---|---|
| Package (num) | Per inhaler | Price | Buy |
| 1 | $52.19 | $52.19 (0%) | 🛒 Add to cart |
| 2 | $47.68 | $104.39 $95.35 (9%) | 🛒 Add to cart |
| 3 | $42.82 | $156.58 $128.47 (18%) | 🛒 Add to cart |
| 4 | $40.90 | $208.77 $163.60 (22%) | 🛒 Add to cart |
| 5 | $38.94 | $260.96 $194.72 (25%) | 🛒 Add to cart |
| 6 | $37.30 | $313.16 $223.83 (29%) | 🛒 Add to cart |
| 7 | $35.85 | $365.35 $250.93 (31%) | 🛒 Add to cart |
| 8 | $34.38 | $417.54 $275.02 (34%) | 🛒 Add to cart |
| 9 | $33.01 | $469.73 $297.10 (37%) | 🛒 Add to cart |
| 10 | $31.72
Best per inhaler | $521.93 $317.17 (39%) | 🛒 Add to cart |
| Product dosage: 400mcg | |||
|---|---|---|---|
| Package (num) | Per inhaler | Price | Buy |
| 1 | $57.21 | $57.21 (0%) | 🛒 Add to cart |
| 2 | $52.69 | $114.42 $105.39 (8%) | 🛒 Add to cart |
| 3 | $46.17 | $171.63 $138.51 (19%) | 🛒 Add to cart |
| 4 | $44.16 | $228.85 $176.65 (23%) | 🛒 Add to cart |
| 5 | $42.16 | $286.06 $210.78 (26%) | 🛒 Add to cart |
| 6 | $40.15 | $343.27 $240.89 (30%) | 🛒 Add to cart |
| 7 | $38.71 | $400.48 $271.00 (32%) | 🛒 Add to cart |
| 8 | $37.14 | $457.69 $297.10 (35%) | 🛒 Add to cart |
| 9 | $35.91 | $514.90 $323.19 (37%) | 🛒 Add to cart |
| 10 | $34.63
Best per inhaler | $572.11 $346.28 (39%) | 🛒 Add to cart |
Foracort Inhaler is a combination bronchodilator and corticosteroid medication designed for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: Budesonide, an anti-inflammatory corticosteroid that reduces swelling and irritation in the airways, and Formoterol, a long-acting beta2-agonist that relaxes the muscles around the airways to improve breathing. This inhaler is intended for regular use to prevent symptoms and exacerbations, not for immediate relief of acute bronchospasm. Proper technique and adherence to prescribed dosing are critical for achieving optimal therapeutic outcomes and maintaining long-term respiratory health.
Features
- Contains Budesonide (inhaled corticosteroid) and Formoterol (long-acting beta2-agonist) in a single metered-dose inhaler
- Available in multiple strength combinations (e.g., Budesonide 100/200/400 mcg + Formoterol 6 mcg per puff)
- Delivers medication directly to the lungs for targeted action with minimal systemic exposure
- Comes with a standardized actuator and dose counter to track remaining inhalations
- Requires prescription and regular medical supervision for use
- Not indicated for rescue relief; must be used alongside a fast-acting bronchodilator if prescribed
Benefits
- Provides dual-action therapy by combining anti-inflammatory and bronchodilator effects in one device
- Reduces frequency and severity of asthma attacks and COPD exacerbations when used regularly
- Improves lung function measurements (FEV1) and overall quality of life for respiratory patients
- Helps decrease reliance on oral corticosteroids and short-acting rescue inhalers over time
- Supports long-term airway remodeling and inflammation control in persistent asthma
- Convenient twice-daily dosing regimen supports adherence and consistent symptom management
Common use
Foracort Inhaler is commonly prescribed for the maintenance treatment of asthma in patients who require both inhaled corticosteroid and long-acting bronchodilator therapy. It is also indicated for symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, particularly those who have significant symptoms despite regular bronchodilator therapy. It is not suitable for children under 6 years of age and should not be used to treat acute asthma attacks or status asthmaticus.
Dosage and direction
The dosage of Foracort Inhaler must be individualized based on disease severity and patient response. For asthma maintenance in adults and adolescents (12 years and older): usually 1-2 inhalations twice daily. For COPD: 2 inhalations twice daily. The maximum recommended dose is 4 inhalations twice daily. Patients should be instructed on proper inhaler technique, including shaking the inhaler well before each use, exhaling fully away from the mouthpiece, placing the mouthpiece between lips, inhaling deeply and steadily while pressing the canister, holding breath for 5-10 seconds, and waiting 30-60 seconds before the second inhalation if prescribed. The mouth should be rinsed with water after each use to prevent oral candidiasis.
Precautions
Patients should be monitored regularly for any signs of systemic corticosteroid effects, particularly with higher doses. Caution is advised in patients with tuberculosis, fungal, bacterial, viral or parasitic infections, or ocular herpes simplex. Use with caution in patients with cardiovascular disorders, especially coronary artery disease, cardiac arrhythmias, and hypertension. May cause paradoxical bronchospasm—if this occurs, discontinue immediately and institute alternative therapy. Be alert for signs of adrenal insufficiency during periods of stress or after transfer from systemic corticosteroids. Monitor bone mineral density in patients at risk for osteoporosis with long-term use. Use the lowest effective dose to minimize systemic exposure.
Contraindications
Hypersensitivity to Budesonide, Formoterol, or any component of the formulation. Not indicated for the relief of acute bronchospasm. Contraindicated in patients with significantly worsening or acutely deteriorating asthma or COPD. Should not be used as the sole treatment for status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required. Not recommended for patients with known untreated fungal, bacterial, or tuberculosis infections of the respiratory tract.
Possible side effects
Common side effects (≥1/100) include: headache, tremor, palpitations, muscle cramps, hoarseness, throat irritation, and oral candidiasis. Less common side effects (≥1/1000, <1/100) may include: tachycardia, anxiety, sleep disturbances, hypokalemia, hyperglycemia, cough, and dysphonia. Rare but serious side effects include: paradoxical bronchospasm, cardiac arrhythmias, angioedema, anaphylactic reactions, adrenal suppression, growth retardation in children, glaucoma, cataracts, and osteoporosis with long-term use. Patients should report any chest pain, increased pulse, nervousness, or worsening respiratory symptoms promptly.
Drug interaction
Concomitant use with other beta-adrenergic drugs may potentiate sympathetic effects. Use with MAO inhibitors, tricyclic antidepressants, and other drugs that prolong QTc interval may increase the risk of ventricular arrhythmias. Diuretics and xanthine derivatives may enhance hypokalemic effects. Ketoconazole and other potent CYP3A4 inhibitors may increase Budesonide plasma levels. Beta-blockers may antagonize the effects of Formoterol and may produce severe bronchospasm in asthmatic patients. Use with disopyramide, procainamide, phenothiazines, and quinidine may prolong QTc interval.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Patients should be educated about the importance of regular use for optimal control but should not exceed the prescribed daily dosage.
Overdose
Overdose may produce symptoms of excessive beta-adrenergic stimulation including tachycardia, arrhythmias, tremor, headache, muscle cramps, dry mouth, nausea, dizziness, fatigue, malaise, hypokalemia, hyperglycemia, and metabolic acidosis. Cardiac arrest may occur with massive overdose. Treatment is supportive and symptomatic. Cardiac monitoring is recommended. Consider the use of a cardioselective beta-blocker in cases of severe cardiovascular symptoms, but with caution in patients with asthma due to risk of bronchospasm. Corticosteroid effects are unlikely with acute overdose but may occur with chronic excessive use.
Storage
Store at room temperature (15-30°C) in a dry place away from direct heat and sunlight. Do not puncture, break, or burn the canister even when empty. Keep away from open flames and sources of ignition. The inhaler should be discarded 3 months after removal from the foil pouch or when the dose counter reads “0,” whichever comes first. Keep out of reach of children and pets. Do not store in damp places like bathrooms.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Foracort Inhaler is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Dosage and treatment duration should be determined by a physician based on individual patient assessment. Patients should not adjust their dosage or discontinue treatment without consulting their healthcare provider. The full prescribing information should be consulted before initiating therapy.
Reviews
Clinical studies have demonstrated that Foracort Inhaler significantly improves lung function and reduces exacerbation rates in both asthma and COPD patients. In a 12-month randomized controlled trial involving moderate to severe asthma patients, those using Foracort showed a 28% reduction in severe exacerbations compared to monotherapy. COPD studies reported a 24% reduction in moderate-to-severe exacerbations and improved quality of life scores. Patients report better symptom control and reduced rescue medication use, though some note the need for proper technique training. Healthcare providers emphasize its role in comprehensive asthma/COPD management programs when used appropriately.